Use of Continuous Glucose Monitors in Publicly-Insured Youth With Type 2 Diabetes - A Pilot and Feasibility Study
Status
Conditions
Treatments
Details and patient eligibility
About
The purpose of this pilot feasibility study is to provide continued CGM access to youth with type 2 diabetes and collect descriptive data about feasibility of use of CGM in youth with type 2 diabetes ages 4 years and older. From this study the investigators hope to learn if CGM use in youth with type 2 diabetes can be tolerated and sustained with good adherence and to describe blood glucose patterns in youth with type 2 diabetes. The primary aim will be to evaluate the feasibility of CGM start and continuation in youth with T2D and describe glucose metrics and patient reported outcomes (PROs). The investigators will pilot and refine a program to test the hypothesis that CGM start and continuation in youth with T2D is feasible and then evaluate glucose metrics and PROs.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- public insurance
- between ages 4-19.99 years inclusive
- diagnosis of T2D (diabetes autoantibody negative) followed in the Pediatric Endocrinology clinic at Stanford Children's Health
- HbA1C greater than 6.5% at enrollment
- interested in starting on a continuous glucose monitor
- have access to a mobile device that is compatible with CGM applications or willing to use CGM receiver provided
Exclusion criteria
- non-T2D diagnosis
- HgA1C < 6.5%
- are not willing to wear CGM
- have private health insurance.
Trial design
Primary purpose
Allocation
Interventional model
Masking
30 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal